TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.

<h4>Background</h4>Clinical immunity to malaria has been associated with humoral immune responses targeting asexual-stage parasite proteins. However, the variability in antibody-driven responses may be influenced by genetic factors in the human host. This study aimed to evaluate the freq...

Full description

Saved in:
Bibliographic Details
Main Authors: Fhabián S Carrión-Nessi, Eva Salazar-Alcalá, David A Forero-Peña, Kellys A Curiel, Mary Lopez-Perez, Mercedes Fernández-Mestre
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-06-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0013262
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849427386170343424
author Fhabián S Carrión-Nessi
Eva Salazar-Alcalá
David A Forero-Peña
Kellys A Curiel
Mary Lopez-Perez
Mercedes Fernández-Mestre
author_facet Fhabián S Carrión-Nessi
Eva Salazar-Alcalá
David A Forero-Peña
Kellys A Curiel
Mary Lopez-Perez
Mercedes Fernández-Mestre
author_sort Fhabián S Carrión-Nessi
collection DOAJ
description <h4>Background</h4>Clinical immunity to malaria has been associated with humoral immune responses targeting asexual-stage parasite proteins. However, the variability in antibody-driven responses may be influenced by genetic factors in the human host. This study aimed to evaluate the frequency of SNPs in the TLR9 gene and their association with IgG antibody responses against PvCSP variants (VK247, VK210, and V-like) and PvMSP-119 among individuals presenting with symptomatic Plasmodium vivax infections in a malaria-endemic region of Venezuela.<h4>Methodology/principal findings</h4>A cross-sectional study was conducted in Bolívar state, Venezuela, involving 210 individuals infected with P. vivax. IgG reactivity against P. vivax recombinant antigens was assessed by ELISA, and three TLR9 gene SNPs (rs5743836, rs352140, and rs187084) were genotyped by PCR. The median age of individuals was 29 years, with the majority being male miners with a prior history of malaria. Over 90% of individuals exhibited IgG antibodies against the three PvCSP variants and PvMSP-119. High responders to the PvCSP variants reported fewer symptoms compared to medium (p < 0.001) and low (p < 0.001) responders. Among the analyzed SNPs, heterozygous genotypes were the most prevalent. Using an overdominant inheritance model, carrying the heterozygous genotype (T/C) for TLR9 gene SNP rs5743836 was associated with lower IgG antibody response against PvCSP VK247 (aOR = 0.26, 95% CI = 0.09 to 0.73, p = 0.0094) and PvCSP V-like (aOR = 0.37, 95% CI = 0.14 to 0.99, p = 0.047). No significant associations between inheritance models for the three SNPs and parasitemia were observed.<h4>Conclusions/significance</h4>These findings suggest that TLR9 gene variability, particularly the heterozygous genotype for SNP rs5743836, may influence the IgG antibody response against PvCSP VK247 and V-like. Identifying genetic traits that impact immune response development could be valuable for malaria vaccine design and implementation.
format Article
id doaj-art-e9e05e244c824ca4ac3a819feccb7f34
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2025-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-e9e05e244c824ca4ac3a819feccb7f342025-08-20T03:29:03ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352025-06-01196e001326210.1371/journal.pntd.0013262TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.Fhabián S Carrión-NessiEva Salazar-AlcaláDavid A Forero-PeñaKellys A CurielMary Lopez-PerezMercedes Fernández-Mestre<h4>Background</h4>Clinical immunity to malaria has been associated with humoral immune responses targeting asexual-stage parasite proteins. However, the variability in antibody-driven responses may be influenced by genetic factors in the human host. This study aimed to evaluate the frequency of SNPs in the TLR9 gene and their association with IgG antibody responses against PvCSP variants (VK247, VK210, and V-like) and PvMSP-119 among individuals presenting with symptomatic Plasmodium vivax infections in a malaria-endemic region of Venezuela.<h4>Methodology/principal findings</h4>A cross-sectional study was conducted in Bolívar state, Venezuela, involving 210 individuals infected with P. vivax. IgG reactivity against P. vivax recombinant antigens was assessed by ELISA, and three TLR9 gene SNPs (rs5743836, rs352140, and rs187084) were genotyped by PCR. The median age of individuals was 29 years, with the majority being male miners with a prior history of malaria. Over 90% of individuals exhibited IgG antibodies against the three PvCSP variants and PvMSP-119. High responders to the PvCSP variants reported fewer symptoms compared to medium (p < 0.001) and low (p < 0.001) responders. Among the analyzed SNPs, heterozygous genotypes were the most prevalent. Using an overdominant inheritance model, carrying the heterozygous genotype (T/C) for TLR9 gene SNP rs5743836 was associated with lower IgG antibody response against PvCSP VK247 (aOR = 0.26, 95% CI = 0.09 to 0.73, p = 0.0094) and PvCSP V-like (aOR = 0.37, 95% CI = 0.14 to 0.99, p = 0.047). No significant associations between inheritance models for the three SNPs and parasitemia were observed.<h4>Conclusions/significance</h4>These findings suggest that TLR9 gene variability, particularly the heterozygous genotype for SNP rs5743836, may influence the IgG antibody response against PvCSP VK247 and V-like. Identifying genetic traits that impact immune response development could be valuable for malaria vaccine design and implementation.https://doi.org/10.1371/journal.pntd.0013262
spellingShingle Fhabián S Carrión-Nessi
Eva Salazar-Alcalá
David A Forero-Peña
Kellys A Curiel
Mary Lopez-Perez
Mercedes Fernández-Mestre
TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.
PLoS Neglected Tropical Diseases
title TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.
title_full TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.
title_fullStr TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.
title_full_unstemmed TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.
title_short TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela.
title_sort tlr9 gene polymorphism 1237t c rs5743836 is associated with low igg antibody response against pvcsp variants in symptomatic p vivax infections in venezuela
url https://doi.org/10.1371/journal.pntd.0013262
work_keys_str_mv AT fhabianscarrionnessi tlr9genepolymorphism1237tcrs5743836isassociatedwithlowiggantibodyresponseagainstpvcspvariantsinsymptomaticpvivaxinfectionsinvenezuela
AT evasalazaralcala tlr9genepolymorphism1237tcrs5743836isassociatedwithlowiggantibodyresponseagainstpvcspvariantsinsymptomaticpvivaxinfectionsinvenezuela
AT davidaforeropena tlr9genepolymorphism1237tcrs5743836isassociatedwithlowiggantibodyresponseagainstpvcspvariantsinsymptomaticpvivaxinfectionsinvenezuela
AT kellysacuriel tlr9genepolymorphism1237tcrs5743836isassociatedwithlowiggantibodyresponseagainstpvcspvariantsinsymptomaticpvivaxinfectionsinvenezuela
AT marylopezperez tlr9genepolymorphism1237tcrs5743836isassociatedwithlowiggantibodyresponseagainstpvcspvariantsinsymptomaticpvivaxinfectionsinvenezuela
AT mercedesfernandezmestre tlr9genepolymorphism1237tcrs5743836isassociatedwithlowiggantibodyresponseagainstpvcspvariantsinsymptomaticpvivaxinfectionsinvenezuela